Forsta AP Fonden Has $97.76 Million Holdings in UnitedHealth Group Incorporated (NYSE:UNH)

Forsta AP Fonden reduced its position in shares of UnitedHealth Group Incorporated (NYSE:UNHGet Rating) by 5.9% in the first quarter, according to the company in its most recent filing with the SEC. The institutional investor owned 191,700 shares of the healthcare conglomerate’s stock after selling 12,000 shares during the quarter. UnitedHealth Group accounts for about 1.1% of Forsta AP Fonden’s investment portfolio, making the stock its 10th biggest holding. Forsta AP Fonden’s holdings in UnitedHealth Group were worth $97,761,000 at the end of the most recent reporting period.

A number of other institutional investors and hedge funds have also bought and sold shares of the company. NorthCrest Asset Manangement LLC grew its stake in shares of UnitedHealth Group by 9.5% in the first quarter. NorthCrest Asset Manangement LLC now owns 518 shares of the healthcare conglomerate’s stock worth $264,000 after acquiring an additional 45 shares during the period. Domani Wealth LLC grew its stake in shares of UnitedHealth Group by 0.7% in the first quarter. Domani Wealth LLC now owns 3,542 shares of the healthcare conglomerate’s stock worth $1,806,000 after acquiring an additional 25 shares during the period. Stratos Wealth Partners LTD. boosted its holdings in shares of UnitedHealth Group by 44.0% in the first quarter. Stratos Wealth Partners LTD. now owns 17,711 shares of the healthcare conglomerate’s stock worth $9,032,000 after buying an additional 5,414 shares during the last quarter. Salvus Wealth Management LLC boosted its holdings in shares of UnitedHealth Group by 23.5% in the first quarter. Salvus Wealth Management LLC now owns 782 shares of the healthcare conglomerate’s stock worth $399,000 after buying an additional 149 shares during the last quarter. Finally, Lake Street Financial LLC boosted its holdings in shares of UnitedHealth Group by 42.9% in the first quarter. Lake Street Financial LLC now owns 3,706 shares of the healthcare conglomerate’s stock worth $1,890,000 after buying an additional 1,112 shares during the last quarter. 87.48% of the stock is currently owned by institutional investors.

Wall Street Analyst Weigh In

A number of equities analysts recently issued reports on the stock. Loop Capital assumed coverage on shares of UnitedHealth Group in a report on Thursday, June 16th. They issued a “buy” rating and a $575.00 price objective on the stock. Cowen raised their price objective on shares of UnitedHealth Group from $512.00 to $596.00 in a report on Monday, April 18th. UBS Group lifted their price target on shares of UnitedHealth Group from $545.00 to $570.00 and gave the company a “neutral” rating in a report on Thursday, July 21st. Credit Suisse Group lifted their price target on shares of UnitedHealth Group from $575.00 to $579.00 and gave the company an “outperform” rating in a report on Monday, July 18th. Finally, Oppenheimer lifted their price target on shares of UnitedHealth Group from $600.00 to $610.00 and gave the company an “outperform” rating in a report on Monday, July 18th. Three analysts have rated the stock with a hold rating, sixteen have given a buy rating and two have assigned a strong buy rating to the company. According to MarketBeat, the company currently has an average rating of “Moderate Buy” and a consensus target price of $582.50.

Insider Activity

In other news, Director Richard T. Burke sold 2,500 shares of the business’s stock in a transaction on Monday, May 16th. The shares were sold at an average price of $493.25, for a total transaction of $1,233,125.00. Following the completion of the sale, the director now directly owns 1,220,000 shares of the company’s stock, valued at $601,765,000. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through the SEC website. In related news, Director Richard T. Burke sold 2,500 shares of the company’s stock in a transaction dated Monday, May 16th. The shares were sold at an average price of $493.25, for a total value of $1,233,125.00. Following the completion of the sale, the director now directly owns 1,220,000 shares of the company’s stock, valued at $601,765,000. The transaction was disclosed in a legal filing with the SEC, which can be accessed through this hyperlink. Also, Director Stephen J. Hemsley sold 99,312 shares of the company’s stock in a transaction dated Tuesday, July 26th. The stock was sold at an average price of $534.27, for a total transaction of $53,059,422.24. Following the completion of the sale, the director now directly owns 787,372 shares of the company’s stock, valued at $420,669,238.44. The disclosure for this sale can be found here. Over the last ninety days, insiders sold 130,144 shares of company stock valued at $69,269,555. 0.40% of the stock is currently owned by company insiders.

UnitedHealth Group Price Performance

UNH traded down $2.15 during trading hours on Friday, hitting $531.60. The company’s stock had a trading volume of 80,190 shares, compared to its average volume of 2,834,317. The business’s 50-day moving average price is $505.90 and its 200-day moving average price is $498.93. UnitedHealth Group Incorporated has a 12 month low of $383.12 and a 12 month high of $553.29. The stock has a market cap of $498.73 billion, a price-to-earnings ratio of 27.87, a P/E/G ratio of 1.67 and a beta of 0.76. The company has a current ratio of 0.77, a quick ratio of 0.78 and a debt-to-equity ratio of 0.60.

UnitedHealth Group (NYSE:UNHGet Rating) last posted its quarterly earnings data on Friday, July 15th. The healthcare conglomerate reported $5.57 earnings per share for the quarter, beating analysts’ consensus estimates of $5.24 by $0.33. UnitedHealth Group had a net margin of 5.95% and a return on equity of 25.45%. The business had revenue of $80.33 billion for the quarter, compared to analysts’ expectations of $79.68 billion. During the same quarter in the previous year, the business posted $4.70 earnings per share. The business’s revenue was up 12.6% compared to the same quarter last year. Sell-side analysts expect that UnitedHealth Group Incorporated will post 21.86 earnings per share for the current fiscal year.

UnitedHealth Group Increases Dividend

The business also recently announced a quarterly dividend, which was paid on Tuesday, June 28th. Stockholders of record on Monday, June 20th were paid a dividend of $1.65 per share. This is a positive change from UnitedHealth Group’s previous quarterly dividend of $1.45. This represents a $6.60 dividend on an annualized basis and a dividend yield of 1.24%. The ex-dividend date was Thursday, June 16th. UnitedHealth Group’s payout ratio is currently 34.46%.

About UnitedHealth Group

(Get Rating)

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. It operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage and well-being services to individuals age 50 and older addressing their needs for preventive and acute health care services, as well as services dealing with chronic disease and other specialized issues for older individuals; Medicaid plans, children's health insurance and health care programs; health and dental benefits; and hospital and clinical services.

See Also

Institutional Ownership by Quarter for UnitedHealth Group (NYSE:UNH)

Receive News & Ratings for UnitedHealth Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for UnitedHealth Group and related companies with MarketBeat.com's FREE daily email newsletter.